SCHEMBL4530466

SCHEMBL4530466

C=NN/C=C\N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16068099 0.69
SCHEMBL19798258 0.61
SCHEMBL13257969 0.60
SCHEMBL10078424 0.60
SCHEMBL19243819 0.59
SCHEMBL1632138 0.57
SCHEMBL27636832 0.57
SCHEMBL4381095 0.57
SCHEMBL12320435 0.55
SCHEMBL5252582 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9795550-B2 Gamma-diketones for treatment and prevention of aging skin and wrinkles SAMUMED, LLC (US) 2017-10-24 US disclosed
EP-2114428-B1 Triazole linked macrocyclic peptides AILERON THERAPEUTICS INC (US) 2012-10-31 EP disclosed
WO-2012068209-A2 BISTHIAZOLE INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION JANSSEN PHARMACEUTICA NV (BE) 2012-05-24 WO disclosed
WO-2012058531-A2 MODULATION OF RESPONSE REGULATORS BY IMIDAZOLE DERIVATIVES NORTH CAROLINA STATE UNIVERSITY (US) 2012-05-03 WO disclosed
WO-2011038097-A2 INDOLIZINE INHIBITORS OF 5-LIPOXYGENASE AMIRA PHARMACEUTICALS, INC. (US) 2011-03-31 WO disclosed
WO-2011038086-A2 INDOLIZINE INHIBITORS OF 5-LIPOXYGENASE AMIRA PHARMACEUTICALS, INC. (US) 2011-03-31 WO disclosed
WO-2010141499-A2 LIGNIN OXIDATION AND PRODUCTS THEREOF STRATEGIC ENZYME APPLICATIONS, INC. (US) 2010-12-09 WO disclosed
WO-2010077603-A1 INHIBITION AND DISPERSION OF BIOFILMS IN PLANTS WITH IMIDAZOLE-TRIAZOLE DERIVATIVES NORTH CAROLINA STATE UNIVERSITY (US) 2010-07-08 WO disclosed
WO-2010062863-A2 COMPOSITIONS CONTAINING SATIOGENS AND METHODS OF USE SATIOGEN PHARMACEUTICALS, INC. (US) 2010-06-03 WO disclosed
WO-2009140683-A1 LIVING COPOLYMER PROTEIN/PEPTIDE HYBRIDS FOR BIOMEDICAL APPLICATIONS RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2009-11-19 WO disclosed
WO-2009131654-A2 INHIBITION AND DISPERSION OF BACTERIAL BIOFILMS WITH IMIDAZOLE-TRIAZOLE DERIVATIVES NORTH CAROLINA STATE UNIVERSITY (US) 2009-10-29 WO disclosed
WO-2009123753-A1 INHIBITION OF BACTERIAL BIOFILMS WITH IMIDAZOLE-PHENYL DERIVATIVES NORTH CAROLINA STATE UNIVERSITY (US) 2009-10-08 WO disclosed